WuXi PharmaTech Selects Labcyte POD™ 810 Platform for High-Throughput Screening
News Dec 10, 2009
WuXi PharmaTech joins the growing number of pharmaceutical companies worldwide that have incorporated the POD system into their compound management and HTS processes.
“With this technology WuXi will remain the leader in pharmaceutical outsourcing—this demonstrates our continuous efforts to build both capabilities and capacity to help our partners to improve the success of discovery and shorten development time," commented Dr Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech.
“Acoustic liquid handling is clearly the method of choice in drug discovery,” said Dr. Qiang Lu, Vice President of Discovery Biology of WuXi PharmaTech. "We are very pleased to incorporate the POD 810 into our systems. It will make our drug discovery efforts significantly more productive while it reduces cost through the elimination of disposable plastic tips. We know that acoustic liquid handling will significantly improve the quality of the data we generate. We are looking forward to a continuing relationship with Labcyte."
The POD 810 plate assembler, a walk-away, out-of-the-box solution, transforms any Echo acoustic liquid handler into a Plates-On-Demand instrument. The POD system is controlled by its revolutionary Intellectual Scheduler with built-in intelligence to automatically adjust workflow to maximize productivity.
"The POD platform is uniquely positioned to advance method standardization across global sites,” said Mark Fischer-Colbrie, president and CEO of Labcyte Inc. “It eliminates the unnecessary delays associated with customized integration.”
“We are very pleased WuXi PharmaTech decided to acquire a Labcyte POD system,” said Sanger Chang, General Manager of Tekon Biotech. “Our exclusive relationship with Labcyte is further validation of our efforts to be the leading supplier of instrument systems for pharmaceutical research to the Chinese market by providing the highest level of technical support and service.”
Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Their research revealed a promising strategy to develop a suitable agent. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.READ MORE